A review of the phase 4 PALADIN data show that steroid-eluting implants lead to good vision, safe outcomes, and reduced burden in patients with DME.
Daniel F. Kiernan, MD, FACS
Advertisement
Articles by Daniel F. Kiernan, MD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
STAAR Surgical terminates proposed acquisition by Alcon
2
Macular laser picks up speed: The technology accelerating retinal therapies
3
PRIMAvera study: Central vision improvement with subretinal implant
4
Treating MacTel: First identify patient candidates and appropriate eye selection
5